The emergence of resistance to drugs used to treat the airborne disease tuberculosis (TB) is one of the most urgent health crises facing mankind. Already the world’s number one killer from an infectious disease with 1.67 million deaths in 2016, resistance to anti-tuberculosis drugs is making TB more difficult to cure.
